Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,813 | 696 | 97.7% |
| Education | $258.69 | 5 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,115 | 161 | $0 (2024) |
| Janssen Biotech, Inc. | $1,136 | 81 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $902.39 | 40 | $0 (2024) |
| Lilly USA, LLC | $705.41 | 45 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $653.13 | 65 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $596.82 | 30 | $0 (2024) |
| PFIZER INC. | $560.56 | 32 | $0 (2024) |
| LEO Pharma Inc. | $502.53 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $482.12 | 26 | $0 (2024) |
| UCB, Inc. | $426.46 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,464 | 80 | Janssen Biotech, Inc. ($299.10) |
| 2023 | $2,249 | 126 | AbbVie Inc. ($582.90) |
| 2022 | $2,623 | 139 | ABBVIE INC. ($500.87) |
| 2021 | $1,283 | 90 | AbbVie Inc. ($224.75) |
| 2020 | $634.15 | 53 | AbbVie Inc. ($242.16) |
| 2019 | $1,149 | 97 | Ortho Dermatologics, a division of Bausch Health US, LLC ($271.76) |
| 2018 | $769.50 | 62 | Lilly USA, LLC ($147.97) |
| 2017 | $899.82 | 54 | LEO Pharma Inc. ($207.42) |
All Payment Transactions
701 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 08/21/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Dermatology | ||||||
| 07/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: Immunology | ||||||
| 07/18/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Immunology | ||||||
| 07/17/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: DERMATOLOGY | ||||||
| 07/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Immunology | ||||||
| 07/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: Immunology | ||||||
| 06/20/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Immunology | ||||||
| 06/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $4.76 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: Immunology | ||||||
| 06/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: Immunology | ||||||
| 06/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: Immunology | ||||||
| 06/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Dermatology | ||||||
| 05/30/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Dermatology | ||||||
| 05/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: Inflammation | ||||||
| 05/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Immunology | ||||||
| 05/14/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Immunology | ||||||
| 05/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Immunology | ||||||
| 05/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Inflammation | ||||||
| 05/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,473 | 3,569 | $251,018 | $92,521 |
| 2022 | 16 | 1,380 | 3,306 | $248,557 | $93,060 |
| 2021 | 16 | 1,346 | 3,210 | $235,899 | $91,998 |
| 2020 | 14 | 1,221 | 2,972 | $184,075 | $64,795 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 274 | 442 | $68,519 | $25,701 | 37.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 305 | 437 | $48,677 | $16,558 | 34.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 119 | 140 | $26,604 | $9,997 | 37.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 194 | 251 | $24,154 | $9,009 | 37.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 251 | 1,708 | $18,446 | $7,684 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 80 | $17,710 | $6,318 | 35.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 60 | 62 | $10,794 | $3,999 | 37.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 58 | 58 | $11,148 | $3,916 | 35.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 28 | 32 | $8,932 | $3,752 | 42.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 15 | 21 | $4,406 | $1,509 | 34.2% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 11 | 11 | $3,349 | $1,425 | 42.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 29 | 29 | $3,600 | $1,340 | 37.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 14 | 18 | $1,600 | $652.26 | 40.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 48 | $1,920 | $476.15 | 24.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 27 | 232 | $1,160 | $184.58 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 339 | 589 | $91,442 | $34,873 | 38.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 284 | 417 | $46,450 | $16,532 | 35.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 104 | 125 | $23,754 | $9,264 | 39.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 228 | 1,346 | $14,537 | $6,475 | 44.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 125 | 154 | $14,781 | $5,946 | 40.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 65 | 71 | $12,360 | $4,711 | 38.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 62 | 62 | $11,910 | $3,834 | 32.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 20 | 25 | $7,547 | $3,014 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 23 | $5,035 | $2,159 | 42.9% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 16 | 25 | $5,246 | $1,664 | 31.7% |
About Dr. Bruce Brumfiel, M.D
Dr. Bruce Brumfiel, M.D is a Dermatology healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699880609.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Brumfiel, M.D has received a total of $11,071 in payments from pharmaceutical and medical device companies, with $1,464 received in 2024. These payments were reported across 701 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($10,813).
As a Medicare-enrolled provider, Brumfiel has provided services to 5,420 Medicare beneficiaries, totaling 13,057 services with total Medicare billing of $342,374. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Dayton, OH
- Active Since 08/20/2006
- Last Updated 06/08/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699880609
Products in Payments
- DUPIXENT (Biological) $1,195
- SKYRIZI (Biological) $1,146
- TREMFYA (Drug) $795.98
- TALTZ (Drug) $705.41
- Sotyktu (Drug) $596.82
- RINVOQ (Biological) $511.60
- EUCRISA (Drug) $503.09
- Cimzia (Drug) $337.09
- DORYX (Drug) $335.63
- REMICADE (Biological) $315.96
- OPZELURA (Drug) $273.55
- ENSTILAR (Drug) $259.27
- ADBRY (Biological) $220.71
- Erivedge (Biological) $216.15
- Humira (Biological) $204.45
- Enbrel (Biological) $203.38
- Otezla (Drug) $202.14
- COSENTYX (Biological) $200.67
- DUOBRII (Drug) $178.15
- Skyrizi (Biological) $141.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Dayton
Rocco Serrao, Md, MD
Dermatology — Payments: $1.5M
Dr. Matthew Bakos, M.d, M.D
Dermatology — Payments: $146,885
Jeffrey Travers, Md, Ph.d, MD, PH.D
Dermatology — Payments: $108,675
Shannon Verma, M.d, M.D
Dermatology — Payments: $12,575
Dr. Brian Russ, M.d, M.D
Dermatology — Payments: $11,676
Suzanne Dundon, M.d, M.D
Dermatology — Payments: $5,054